Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12477328rdf:typepubmed:Citationlld:pubmed
pubmed-article:12477328lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:12477328lifeskim:mentionsumls-concept:C0018826lld:lifeskim
pubmed-article:12477328lifeskim:mentionsumls-concept:C1541923lld:lifeskim
pubmed-article:12477328lifeskim:mentionsumls-concept:C0079633lld:lifeskim
pubmed-article:12477328lifeskim:mentionsumls-concept:C1456820lld:lifeskim
pubmed-article:12477328pubmed:issue10lld:pubmed
pubmed-article:12477328pubmed:dateCreated2002-12-12lld:pubmed
pubmed-article:12477328pubmed:abstractTextThe embedding of bacteria in the vegetation of infective endocarditis impedes the penetration of phagocytic cells. IL-8 has a stimulating effect on the immune system, particularly with respect to chemotaxis and activation of granulocytes. Tumor necrosis factor alpha (TNF-alpha) is 1 of the major proinflammatory cytokines. IL-8 and TNF-alpha were visualized by means of immunohistochemistry in paraffin-embedded heart valve biopsies from 6 patients with infective endocarditis who required cardiac surgery during the active phase of the infection. In 5/6 patients there were signs of inflammation, and in these patients IL-8- and TNF-alpha-containing cells were visualized in the heart valve stromas or vegetations. The largest numbers of IL-8-containing cells, and the greatest amount of inflammation, were seen in patients with short preoperative treatment courses. No such relationships were seen with respect to TNF-alpha-containing cells. These observations may suggest that the occurrence of IL-8-containing cells in infected heart valves could be used as a marker of disease activity.lld:pubmed
pubmed-article:12477328pubmed:languageenglld:pubmed
pubmed-article:12477328pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12477328pubmed:citationSubsetIMlld:pubmed
pubmed-article:12477328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12477328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12477328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12477328pubmed:statusMEDLINElld:pubmed
pubmed-article:12477328pubmed:issn0036-5548lld:pubmed
pubmed-article:12477328pubmed:authorpubmed-author:EkdahlChriste...lld:pubmed
pubmed-article:12477328pubmed:authorpubmed-author:BroqvistMatsMlld:pubmed
pubmed-article:12477328pubmed:authorpubmed-author:FranzénStefan...lld:pubmed
pubmed-article:12477328pubmed:authorpubmed-author:LjunghusenOlo...lld:pubmed
pubmed-article:12477328pubmed:authorpubmed-author:MallerRolfRlld:pubmed
pubmed-article:12477328pubmed:authorpubmed-author:SanderBirgitt...lld:pubmed
pubmed-article:12477328pubmed:issnTypePrintlld:pubmed
pubmed-article:12477328pubmed:volume34lld:pubmed
pubmed-article:12477328pubmed:ownerNLMlld:pubmed
pubmed-article:12477328pubmed:authorsCompleteYlld:pubmed
pubmed-article:12477328pubmed:pagination759-62lld:pubmed
pubmed-article:12477328pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12477328pubmed:meshHeadingpubmed-meshheading:12477328...lld:pubmed
pubmed-article:12477328pubmed:meshHeadingpubmed-meshheading:12477328...lld:pubmed
pubmed-article:12477328pubmed:meshHeadingpubmed-meshheading:12477328...lld:pubmed
pubmed-article:12477328pubmed:meshHeadingpubmed-meshheading:12477328...lld:pubmed
pubmed-article:12477328pubmed:meshHeadingpubmed-meshheading:12477328...lld:pubmed
pubmed-article:12477328pubmed:meshHeadingpubmed-meshheading:12477328...lld:pubmed
pubmed-article:12477328pubmed:meshHeadingpubmed-meshheading:12477328...lld:pubmed
pubmed-article:12477328pubmed:meshHeadingpubmed-meshheading:12477328...lld:pubmed
pubmed-article:12477328pubmed:meshHeadingpubmed-meshheading:12477328...lld:pubmed
pubmed-article:12477328pubmed:meshHeadingpubmed-meshheading:12477328...lld:pubmed
pubmed-article:12477328pubmed:meshHeadingpubmed-meshheading:12477328...lld:pubmed
pubmed-article:12477328pubmed:meshHeadingpubmed-meshheading:12477328...lld:pubmed
pubmed-article:12477328pubmed:meshHeadingpubmed-meshheading:12477328...lld:pubmed
pubmed-article:12477328pubmed:meshHeadingpubmed-meshheading:12477328...lld:pubmed
pubmed-article:12477328pubmed:meshHeadingpubmed-meshheading:12477328...lld:pubmed
pubmed-article:12477328pubmed:meshHeadingpubmed-meshheading:12477328...lld:pubmed
pubmed-article:12477328pubmed:meshHeadingpubmed-meshheading:12477328...lld:pubmed
pubmed-article:12477328pubmed:meshHeadingpubmed-meshheading:12477328...lld:pubmed
pubmed-article:12477328pubmed:meshHeadingpubmed-meshheading:12477328...lld:pubmed
pubmed-article:12477328pubmed:meshHeadingpubmed-meshheading:12477328...lld:pubmed
pubmed-article:12477328pubmed:year2002lld:pubmed
pubmed-article:12477328pubmed:articleTitleIL-8 and tumor necrosis factor alpha in heart valves from patients with infective endocarditis.lld:pubmed
pubmed-article:12477328pubmed:affiliationDepartment of Infectious Diseases, University Hospital of Linköping, Sweden. Christer.Ekdahl@inf.liu.selld:pubmed
pubmed-article:12477328pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12477328pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:12477328pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12477328lld:pubmed